Stocklytics Platform
Asset logo for symbol TNGX
Tango Therapeutics
TNGX52
$2.66arrow_drop_up1.52%$0.04
Penny Stock
Asset logo for symbol TNGX
TNGX52

$2.66

arrow_drop_up1.52%

Income Statement (TNGX)

itemSep 2024Jun 2024Mar 2024Dec 2023Sep 2023
EBIT-$32.87M-$29.55M-$42.25M-$35.01M-$25.62M
EBITDA-$32.25M-$28.92M-$41.63M-$34.39M-$25.01M
gross Profit$11.60M$19.24M$5.84M$4.81M$10.11M
NET Income-$29.16M-$25.55M-$37.91M-$30.76M-$22.26M
total Revenue$11.60M$19.87M$6.47M$5.43M$10.73M

Balance Sheet (TNGX)

itemSep 2024Jun 2024Mar 2024Dec 2023Sep 2023
cash Equivalents-----
net Debt-$15.52M-$13.72M-$22.92M-$27.46M-$19.02M
stockholders Equity$229.17M$247.67M$264.45M$253.10M$276.59M
total Assets$352.41M$381.45M$406.22M$402.56M$428.18M
total Debt$37.62M$37.83M$38.23M$38.92M$39.50M
total Liabilities$123.24M$133.78M$141.77M$149.45M$151.59M

Cash Flow (TNGX)

itemSep 2024Jun 2024Mar 2024Dec 2023Sep 2023
financing Cash Flow$2.40M$1.31M$42.98M$1.46M$80.28M
free Cash Flow-$33.50M-$23.92M-$38.05M-$27.69M-$31.15M
investing Cash Flow-----
operating Cash Flow-$33.39M-$23.60M-$37.85M-$27.46M-$31.13M

Tango Therapeutics (TNGX) Financials

The income statement of Tango Therapeutics, Inc. (TNGX) provides a comprehensive overview of the company's financial performance. It shows the revenue generated by the company, as well as the expenses incurred during a specific period. The net income from stockholders represents the profit earned by the company after deducting all expenses and taxes. This is an important metric that indicates the overall profitability of the company. EBIT and EBITDA are also crucial financial indicators that measure the company's operating performance. EBIT stands for Earnings Before Interest and Taxes, while EBITDA represents Earnings Before Interest, Taxes, Depreciation, and Amortization. These metrics help evaluate a company's profitability before accounting for interest, taxes, and non-cash expenses. Gross profit refers to the revenue remaining after deducting the cost of goods sold. It is an essential indicator of the company's ability to generate profit from its core operations.
The balance sheet of Tango Therapeutics, Inc. (TNGX) provides a snapshot of the company's financial position at a specific point in time. It includes the company's total assets, total liabilities, and stockholders' equity. Total assets represent the company's resources, including cash, investments, property, and equipment. Total liabilities include the company's debts and other obligations. Stockholders' equity is the residual interest in the company's assets after deducting liabilities. It represents the ownership interest of the company's shareholders. Cash equivalents are highly liquid assets that can be readily converted into cash. These include short-term investments with original maturities of three months or less. Net debt is calculated by subtracting a company's cash and cash equivalents from its total debt. It provides an indication of the company's ability to meet its financial obligations. The cash flow statement of Tango Therapeutics, Inc. (TNGX) shows the cash generated and used by the company during a specific period. It includes operating cash flow, investing cash flow, and financing cash flow. Operating cash flow represents the cash generated from the company's core operations, excluding investments and financing activities. Investing cash flow includes the cash used for acquiring or disposing of assets. Financing cash flow includes the cash from or used for borrowing, repaying debt, or issuing and repurchasing equity. Free cash flow is the cash available to the company after deducting capital expenditures necessary to maintain or expand its asset base. It is a crucial indicator of the company's financial health.
add Tango Therapeutics to watchlist

Keep an eye on Tango Therapeutics

Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.

Take Your Investments to a Whole New Level